Chronic Elamipretide (MTP-131) Therapy Improves Left Ventricular and Mitochondrial Function in a Canine Advanced Heart Failure Model | RemedyX Labs Research Library

A research summary of Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure, examining chronic elamipretide (mtp-131) therapy improves left ventricular and mitochondrial function in a canine advanced heart failure model. Cited source and RUO context from RemedyX Labs.